No abstract available
Keywords:
COVID-19; Microparticles; PF4; Thrombocytopenia; Thrombosis; Vaccine.
MeSH terms
-
Ad26COVS1
-
Autoantibodies / blood
-
Blood Coagulation / drug effects*
-
Blood Platelets / drug effects*
-
Blood Platelets / immunology
-
Blood Platelets / metabolism
-
COVID-19 Vaccines / administration & dosage
-
COVID-19 Vaccines / adverse effects*
-
Cell-Derived Microparticles / drug effects*
-
Cell-Derived Microparticles / immunology
-
Cell-Derived Microparticles / metabolism
-
ChAdOx1 nCoV-19
-
Female
-
Humans
-
Male
-
Middle Aged
-
Phosphatidylserines / metabolism
-
Platelet Factor 4 / immunology
-
Purpura, Thrombocytopenic, Idiopathic / blood
-
Purpura, Thrombocytopenic, Idiopathic / chemically induced*
-
Purpura, Thrombocytopenic, Idiopathic / diagnosis
-
Purpura, Thrombocytopenic, Idiopathic / immunology
-
Receptors, IgG / metabolism
-
Risk Factors
-
Sinus Thrombosis, Intracranial / blood
-
Sinus Thrombosis, Intracranial / chemically induced*
-
Sinus Thrombosis, Intracranial / diagnosis
-
Thromboplastin / metabolism
-
Vaccination / adverse effects*
Substances
-
Ad26COVS1
-
Autoantibodies
-
COVID-19 Vaccines
-
FCGR2A protein, human
-
PF4 protein, human
-
Phosphatidylserines
-
Receptors, IgG
-
Platelet Factor 4
-
Thromboplastin
-
ChAdOx1 nCoV-19